In Vitro Fertilization /IVF Market

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) (2022 - 2026)

Report Code: MD 4467 Nov, 2021, by marketsandmarkets.com

[241 Pages Report] The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors propelling the growth of this market include greater public awareness about infertility and the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain extent.

In vitro fertilization /IVF Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global in vitro fertilization market

COVID-19 pandemic triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women undergoing IVF procedures. In India, 30 lakh people seek IVF every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles worldwide. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic.

In vitro fertilization  Market Dynamics

Driver:   Growth in  median age of first-time mothers

Over the years, the median age of first-time mothers has increased significantly across the globe. This trend can largely be attributed to improved contraceptive techniques, late marriages, and the growing number of women prioritizing their careers over starting a family. According to the data published by Australian Institute of Health and Welfare 2021, in Australia the average age of first-time mothers increased from 27.9 years in 2009 to 31.9 years in 2019. With the median age for first-time mothers increasing, a growing number of women are expected to face difficulties in conceiving naturally. In this scenario, an increasing number of women are forced to opt for IVF treatments; this is expected to drive the growth of the IVF market in the coming years.

Restraint: High costs associated with IVF procedures

More than 2.5 million vitro fertilization (IVF) cycles are performed every year worldwide. The cost of IVF treatment varies from country to country due to the lack of reimbursement policies. A lack of insurance coverage and the poor reimbursement scenario in some parts of the world are limiting the growth of this market.

Opportunity: Increasing  Medical Tourism in Emerging Nations

The medical tourism industry in emerging countries is thriving owing to a number of factors. Brazil has ~150 centers offering infertility treatments and over 20 medical centers [Source: Fertility Treatment Abroad]. A typical IVF cycle in the US costs around USD 12,000, whereas in Brazil, the same can be completed in USD 4,000. With more than 500 individual IVF centers, India is one of the most affordable destinations for in vitro fertilization (IVF) and other infertility treatments worldwide. Healthcare treatments cost up to 90% less in India as compared to the USA typical IVF cycle in the US costs around USD 12,000, while in India, the same can be completed in USD 2,000–USD 3,000.

Challenge: Reducing efficacy of infertility treatment among patients with advancing age

The changing social scenario has resulted in an increasing number of older women seeking help from infertility clinics. The risk of complications in pregnancy and childbirth also increases with age. A woman aged 35 or above is 2.5 times more prone to have a miscarriage or stillbirth than a woman aged less than 35, whereas a woman aged above 40 is more than five times prone to have a miscarriage or stillbirth than a woman under 35 years of age. The declining success rates of IVF treatment procedures in patients with advancing age has become one of the major challenge for IVF market.

    The equipment to capture the largest share in in vitro fertilization market, by products during the forecast period.

    The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the increasing number of IVF procedures and introduction of highly advanced IVF equipment by well-established manufacturers in the market.

    The fresh non-donor segment to capture the largest market share of in vitro fertilization market, by the type of cycle  in 2021.

    The fresh non-donor segment captured the largest share of the market cycles during the forecast period. High success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.

    The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market, by type, in 2021.

    The IVF with ICSI segment registered the highest growth rate of the market. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period.

    The fertility clinics segment accounted for the largest share of the in vitro fertilization market, by end user, in 2021.

    The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, growing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.

    In vitro fertilization /IVF Market by Region

    To know about the assumptions considered for the study, download the pdf brochure

    Asia Pacific  is the largest regional market for in vitro fertilization market

    Asia Pacific dominates the market. Significant rise in the medical tourism, Increase in the awareness of availability of in vitro fertilization procedures, reduced IVF treatment procedures, growing fertility clinics in the region, rising healthcare expenditures, and growing adoption of assisted reproductive technology in the emerging nations.

    Key Market Players

    The prominent players operating in the global in vitro fertilization market include The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany).

    THE COOPER COMPANIES, INC.

    The Cooper Companies operates through two business units, namely, CooperVision (CVI) and CooperSurgical (CSI). The company offers a wide range of products and services focused on women’s health, fertility, and diagnostics through its CooperSurgical business segment. This business unit markets its products under various brand names, such as ORIGIO (provides in vitro fertilization (IVF) products), Reprogenetics (provides genetic testing solutions), and LifeGlobal (providing media products as well as IVF laboratory air filtration products). Through offering a broad range of innovative technologies and services to clinicians and patients worldwide, the company aims to further strengthen its position in the market, by pursuing the strategy of acquisitions.

    The company commercializes its products in over 100 countries and has its presence across the US, Europe, and the RoW. Some of its major subsidiaries include CooperVision International Holding Company (UK), Ocular Sciences SAS (France), CooperSurgical, Inc. (US), CooperSurgical Holdings Ltd. (UK), Cooper Medical, Inc. (US), The Cooper Companies Global Holdings LP (UK), Research Instruments Ltd. (UK), and TCC Holdings S.a.r.l (Luxembourg).

    Get online access to the report on the World's First Market Intelligence Cloud

    • Easy to Download Historical Data & Forecast Numbers
    • Company Analysis Dashboard for high growth potential opportunities
    • Research Analyst Access for customization & queries
    • Competitor Analysis with Interactive dashboard
    • Latest News, Updates & Trend analysis
    Request Sample

    Scope of the Report

    Report Metric

    Details

    Market Size Available for Years

    2019–2026

    Base Year Considered

    2020

    Forecast Period

    2021–2026

    Forecast Units

    Value (USD)

    Segments Covered

    Product, cycle, Type, End user

    Geographies Covered

    North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA

    Companies Covered

    The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Gynotec B.V. (Netherlands

    This research report categorizes the in vitro fertilization market based on product, cycle, type, end user, and region

    By Product

    • Equipment
      • Sperm Analyzer Systems
      • Imaging Systems
      • Ovum Aspiration Pumps
      • Micromanipulator Systems
      • Incubators
      • Gas Analyzers
      • Laser Systems
      • Cryosystems
      • Sperm Separation Devices
      • IVF Cabinets
      • Anti-vibration Tables
      • Witness Systems
      • Other Equipments
    • Reagents & Media
      • Cryopreservation Media
      • Embryo Culture Media
      • Ovum Processing Media
      • Sperm Processing Media
    • Accessories

    By Cycle

    • Fresh Non-donor IVF Cycles
    •  Frozen Non-donor IVF Cycles
    •  Frozen Donor IVF Cycles
    •  Fresh Donor IVF Cycle

    By Type

    • Conventional IVF
    • IVF with ICSI
    • IVF with Donar Eggs
    • Others

    By End User

    • Fertility Clinics
    • Hospitals & Surgical Centers
    • Cryobanks
    • Research Institutes

    By Region

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • RoEU
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • RoAPAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East and Africa

    Recent Developments

    • In 2021, Hamilton Thorne Ltd. received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
    • In 2021, CooperSurgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.
    • In 2020, FUJIFILM Irvine Scientific announced the launch of Vit Kit-NX, a vitrification media solution.
    • In 2020, Genea Limited collaborated with Hamilton Thorne Ltd. to commercialize Genea limited fertility products in the US and Canada.

    Frequently Asked Questions (FAQs):

    To speak to our analyst for a discussion on the above findings, click Speak to Analyst

    TABLE OF CONTENTS

    1 INTRODUCTION (Page No. - 30)
        1.1 OBJECTIVES OF THE STUDY
        1.2 MARKET DEFINITION
               1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
        1.3 MARKET SCOPE
               1.3.1 MARKETS COVERED
               1.3.2 YEARS CONSIDERED FOR THE STUDY
        1.4 CURRENCY USED FOR THE STUDY
        1.5 MAJOR MARKET STAKEHOLDERS
        1.6 SUMMARY OF CHANGES

    2 RESEARCH METHODOLOGY (Page No. - 35)
        2.1 RESEARCH DATA
               FIGURE 1 RESEARCH DESIGN
               2.1.1 SECONDARY DATA
                        2.1.1.1 Secondary sources
               2.1.2 PRIMARY DATA
                        FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL MARKET
        2.2 MARKET ESTIMATION METHODOLOGY
               FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
               2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
               2.2.2 USAGE -BASED MARKET ESTIMATION
                        FIGURE 4 MARKET SIZE ESTIMATION: GLOBAL MARKET BASED ON PRODUCT UTILIZATION METHODOLOGY
                        FIGURE 5 MARKET SIZE ESTIMATION: IN VITRO FERTILIZATION MARKET BASED ON REVENUE MAPPING METHODOLOGY
               2.2.3 PRIMARY RESEARCH VALIDATION
        2.3 DATA TRIANGULATION
               FIGURE 6 DATA TRIANGULATION METHODOLOGY
        2.4 RESEARCH ASSUMPTIONS
        2.5 RESEARCH LIMITATIONS

    3 EXECUTIVE SUMMARY (Page No. - 44)
        FIGURE 7 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
        FIGURE 8 GLOBAL MARKET, BY REAGENTS & MEDIA, 2021 VS. 2026 (USD MILLION)
        FIGURE 9 GLOBAL MARKET, BY CYCLE, 2021 VS. 2026 (USD MILLION)
        FIGURE 10 GLOBAL MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
        FIGURE 11 GLOBAL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
        FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE INGLOBAL MARKET

    4 PREMIUM INSIGHTS (Page No. - 48)
        4.1 IN VITRO FERTILIZATION MARKET OVERVIEW
               FIGURE 13 DELAYED PREGNANCY IN WOMEN IS KEY GROWTH DRIVER OF IVF MARKET
        4.2 GLOBAL MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
               FIGURE 14 REAGENTS AND MEDIA SEGMENT TO REGISTER HIGHEST GROWTH IN GLOBAL MARKET DURING FORECAST PERIOD
        4.3 GLOBAL MARKET, BY TYPE OF CYCLE, 2021 VS. 2026 (USD MILLION)
               FIGURE 15 FRESH NON-DONOR SEGMENT HOLDS LARGEST SHARE OF GLOBAL MARKET
        4.4 GLOBAL MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
               FIGURE 16 IVF WITH ICSI SEGMENT TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
        4.5 GLOBAL MARKET SHARE, BY END USER, 2021
               FIGURE 17 FERTILITY CENTERS EXHIBIT LARGEST DEMAND FOR IN VITRO FERTILIZATION PRODUCTS
        4.6 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT AND COUNTRY (2021)
               FIGURE 18 EQUIPMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF GLOBAL MARKET IN APAC
               FIGURE 19 APAC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD (2021–2026)

    5 MARKET OVERVIEW (Page No. - 53)
        5.1 INTRODUCTION
        5.2 MARKET DYNAMICS
               FIGURE 20 IVF MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
               5.2.1 DRIVERS
                        5.2.1.1 Increase in median age of first-time mothers
                        5.2.1.2 Declining fertility rate
                        5.2.1.3 Rising number of fertility clinics worldwide
                        5.2.1.4 Male infertility on the rise
                        5.2.1.5 Growing rate of obesity and increased consumption of alcohol
                        5.2.1.6 Technological advancements and product innovation
                                   5.2.1.6.1 Advancements in IVF devices
                                   5.2.1.6.2 Growing use of time-lapse technology worldwide
                        5.2.1.7 Increasing public-private funding
                        5.2.1.8 Government initiatives to promote IVF treatments
               5.2.2 RESTRAINTS
                        5.2.2.1 High costs associated with IVF procedures
                                   TABLE 1 IVF COSTS
                        5.2.2.2 Restrictive regulations and ethical concerns
               5.2.3 OPPORTUNITIES
                        5.2.3.1 Growth opportunities in emerging markets
                                   5.2.3.1.1 Increasing medical tourism
                        5.2.3.2 Use of fertility treatment options by single parents and same-sex couples
               5.2.4 CHALLENGES
                        5.2.4.1 Reducing efficacy of infertility treatment among patients with advancing age
        5.3 REGULATORY LANDSCAPE
               5.3.1 NORTH AMERICA
                        5.3.1.1 US
                        5.3.1.2 Canada
               5.3.2 EUROPE
               5.3.3 ASIA PACIFIC
                        5.3.3.1 India
                        5.3.3.2 Japan
                                   TABLE 2 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
        5.4 COVID-19 IMPACT ON THE IVF MARKET
               FIGURE 21 SIX-MONTH DELAY IN IVF - % REDUCTION IN LIVE BIRTHS IN 2020
               FIGURE 22 12-MONTH DELAY IN IVF - % REDUCTION IN LIVE BIRTHS
        5.5 VALUE CHAIN ANALYSIS
               FIGURE 23 VALUE CHAIN OF THE IVF MARKET
        5.6 PRICING TREND ANALYSIS
               TABLE 3 AVERAGE PRICE OF IVF EQUIPMENT AND MEDIA, BY COUNTRY, 2020 (USD)
        5.7 PORTER’S FIVE FORCES ANALYSIS
               TABLE 4 IVF MARKET: PORTER’S FIVE FORCES ANALYSIS
               5.7.1 THREAT OF NEW ENTRANTS
                        FIGURE 24 THREAT OF NEW ENTRANTS
               5.7.2 THREAT OF SUBSTITUTES
                        FIGURE 25 THREAT OF SUBSTITUTES
               5.7.3 BARGAINING POWER OF SUPPLIERS
                        FIGURE 26 BARGAINING POWER OF SUPPLIERS
               5.7.4 BARGAINING POWER OF BUYERS
                        FIGURE 27 BARGAINING POWER OF BUYERS
               5.7.5 INTENSITY OF COMPETITIVE RIVALRY
                        FIGURE 28 INTENSITY OF COMPETITIVE RIVALRY
        5.8 ECOSYSTEM COVERAGE

    6 IN VITRO FERTILIZATION MARKET, BY PRODUCT (Page No. - 71)
        6.1 INTRODUCTION
               TABLE 5 GLOBAL MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        6.2 EQUIPMENT
               TABLE 6 GLOBAL MARKET, BY EQUIPMENT, 2019–2026 (USD MILLION)
               TABLE 7 GLOBAL MARKET, BY REAGENTS & MEDIA 2019–2026 (USD MILLION)
               TABLE 8 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY CYCLE, 2019–2026 (USD MILLION)
               TABLE 9 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 10 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY END USER, 2019–2026 (USD MILLION)
               TABLE 11 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
               6.2.1 IMAGING SYSTEMS
                        6.2.1.1 Increasing use during IVF procedures to drive market
                                   TABLE 12 IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 13 IMAGING SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 14 IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 15 IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.2 SPERM SEPARATION SYSTEMS
                        6.2.2.1 Wide range of applications in fertility procedures
                                   TABLE 16 SPERM SEPARATION SYSTEM MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 17 SPERM SEPARATION SYSTEM MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 18 SPERM ANALAYZER SYSTEM MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 19 SPERM SEPARATION SYSTEM MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.3 OVUM ASPIRATION PUMPS
                        6.2.3.1 Facilitate retrieval and protection of oocytes
                                   TABLE 20 OVUM ASPIRATION PUMPS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 21 OVUM ASPIRATION PUMPS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 22 OVUM ASPIRATION PUMPS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 23 OVUM ASPIRATION PUMPS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.4 MICROMANIPULATOR SYSTEMS
                        6.2.4.1 Growing demand due to rising infertility rates
                                   TABLE 24 MICROMANIPULATOR SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 25 MICROMANIPULATOR SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 26 MICROMANIPULATOR SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 27 MICROMANIPULATOR SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)
                        6.2.4.2 Technological advancements drive market growth
                                   TABLE 28 INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 29 INCUBATORS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 30 INCUBATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 31 INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.5 GAS ANALYZERS
                        6.2.5.1 Increasing use of incubators in IVF labs to drive demand
                                   TABLE 32 GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 33 GAS ANALYZERS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 34 GAS ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 35 GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.6 LASER SYSTEMS
                        6.2.6.1 Multiple applications boost demand
                                   TABLE 36 LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 37 LASER SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 38 LASER SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 39 LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.7 CRYOSYSTEMS
                        6.2.7.1 High demand due to growing desire among women to extend childbearing years
                                   TABLE 40 CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 41 CRYOSYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 42 CRYOSYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 43 CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.8 CABINETS
                        6.2.8.1 Offer high levels of protection during IVF procedures
                                   TABLE 44 CABINETS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 45 CABINETS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 46 CABINETS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 47 CABINETS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.9 ANTI-VIBRATION TABLES
                        6.2.9.1 Ergonomic design offers ease during IVF procedure
                                   TABLE 48 ANTI-VIBRATION TABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 49 ANTI-VIBRATION TABLES MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 50 ANTI-VIBRATION TABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 51 ANTI-VIBRATION TABLES MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.10 WITNESS SYSTEMS
                        6.2.10.1 Growing demand due to ability to reduce human error
                                   TABLE 52 WITNESS SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 53 WITNESS SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 54 WITNESS SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 55 WITNESS SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.2.11 ACCESSORIES
                         TABLE 56 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                         TABLE 57 ACCESSORIES MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                         TABLE 58 ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                         TABLE 59 ACCESSORIES MARKET, BY END USER, 2019–2026 (USD MILLION)
        6.3 REAGENTS & MEDIA
               TABLE 60 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 61 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION)
               TABLE 62 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 63 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
               TABLE 64 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
               6.3.1 EMBRYO CULTURE MEDIA
                        6.3.1.1 Help improve embryo during development phase
                                   TABLE 65 EMBRYO CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 66 EMBRYO CULTURE MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 67 EMBRYO CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 68 EMBRYO CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.3.2 CRYOPRESERVATION MEDIA
                        6.3.2.1 Offers preservation of embryo, resulting in potential fertility
                                   TABLE 69 CRYOPRESERVATION MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 70 CRYOPRESERVATION MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 71 CRYOPRESERVATION MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 72 CRYOPRESERVATION MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.3.3 SPERM PROCESSING MEDIA
                        6.3.3.1 Growing number of IVF procedure using donor sperms to fuel the demand of sperm processing media
                                   TABLE 73 SPERM PROCESSING MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 74 SPERM PROCESSING MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 75 SPERM PROCESSING MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 76 SPERM PROCESSING MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
               6.3.4 OVUM PROCESSING MEDIA
                        6.3.4.1 Prevents oocytes from ice crystal formation, forming long term storage
                                   TABLE 77 OVUM PROCESSING MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                   TABLE 78 OVUM PROCESSING MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                                   TABLE 79 OVUM PROCESSING MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 80 OVUM PROCESSING MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)

    7 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE (Page No. - 110)
        7.1 INTRODUCTION
               TABLE 81 COMPARISON BETWEEN FRESH AND FROZEN EGG CYCLES
               TABLE 82 GLOBAL MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION)
        7.2 FRESH NON-DONOR
               7.2.1 INCREASE EFFECTIVENESS OF FRESH NON DONOR CYCLE TO INCREASE ITS ADOPTION
                        TABLE 83 FRESH NON-DONOR MARKET, BY REGION, 2019–2026 (USD MILLION)
        7.3 FROZEN NON-DONOR
               7.3.1 BENEFITS OFFERED SUCH AS LONG-TERM STORAGE OF FROZEN EGGS TO ACCELERATE THE GROWTH OF FROZEN-NON DONOR CYCLE
                        TABLE 84 FROZEN NON-DONOR MARKET, BY REGION, 2019–2026 (USD MILLION)
        7.4 FROZEN DONOR
               7.4.1 INCREASED AFFORDABILITY, AND EASE OF IMPLANTATION OF FROZEN DONOR CYCLE PROCESS TO SUPPORT THE GROWTH
                        TABLE 85 FROZEN DONOR MARKET, BY REGION, 2019–2026 (USD MILLION)
        7.5 FRESH DONOR
               7.5.1 INCREASED CHANCES OF HAVING ADDITIONAL EMBRYOS FROZEN THROUGH THIS CYCLE TO BOOST ITS ADOPTION
                        TABLE 86 FRESH DONOR MARKET, BY REGION, 2019–2026 (USD MILLION)

    8 IN VITRO FERTILIZATION MARKET, BY TYPE (Page No. - 115)
        8.1 INTRODUCTION
               TABLE 87 GLOBAL MARKET, BY TYPE, 2019–2026 (USD MILLION)
        8.2 CONVENTIONAL IVF
               8.2.1 DECLINING FEMALE FERTILITY TO INCREASE THE PRACTICE OF CONVENTIONAL IVF METHOD.
                        TABLE 88 CONVENTIONAL IVF MARKET, BY REGION, 2019–2026 (USD MILLION)
        8.3 IVF WITH ICSI
               8.3.1 GROWING AWARENESS ABOUT THE HIGHER SUCCESS RATE OF IVF OFFERED TO BOOST THE GROWTH OF IVF WITH ICSI PROCEDURE
                        TABLE 89 IVF WITH ICSI MARKET, BY REGION, 2019–2026 (USD MILLION)
        8.4 IVF WITH DONOR EGGS
               8.4.1 USE OF DONOR EGGS DURING IVF CYCLE HAS RESULTED IN INCREASED CHANCES OF PREGNANCY, BOOSTING ITS GROWTH
                        TABLE 90 IVF WITH DONOR EGGS MARKET, BY REGION, 2019–2026 (USD MILLION)
        8.5 OTHERS
               8.5.1 INTRODUCTION OF NEW IVF DEVICES TO SUPPORT THE GROWTH OTHER SEGMENT
                        TABLE 91 OTHERS MARKET, BY REGION, 2019–2026 (USD MILLION)

    9 IN VITRO FERTILIZATION MARKET, BY END USER (Page No. - 120)
        9.1 INTRODUCTION
               TABLE 92 GLOBAL MARKET, BY END USER, 2019–2026 (USD MILLION)
        9.2 FERTILITY CLINICS
               9.2.1 GROWING NUMBER OF IVF CLINICS WORLDWIDE DRIVE SEGMENT GROWTH
                        TABLE 93 GLOBAL MARKET FOR FERTILITY CLINICS, BY REGION, 2019–2026 (USD MILLION)
        9.3 HOSPITALS AND SURGICAL CENTERS
               9.3.1 GOVERNMENT INITIATIVES TO INCREASE NUMBER OF HOSPITALS EQUIPPED TO PERFORM IVF PROCEDURES CONTRIBUTE TO MARKET GROWTH
                        TABLE 94 GLOBAL MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
        9.4 RESEARCH INSTITUTES
               9.4.1 IMPROVED CLINICAL EFFICACY OF IVF OPTIONS AIDS MARKET GROWTH
                        TABLE 95 GLOBAL MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
        9.5 CRYOBANKS
               9.5.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS DRIVE DEMAND FOR CRYOBANKS
                        TABLE 96 GLOBAL MARKET FOR CRYOBANKS, BY REGION, 2019–2026 (USD MILLION)

    10 IN VITRO FERTILIZATION MARKET, BY REGION (Page No. - 126)
         10.1 INTRODUCTION
                 TABLE 97 GLOBAL MARKET, BY REGION, 2019–2026 (USD MILLION)
         10.2 ASIA PACIFIC
                 FIGURE 29 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET SNAPSHOT
                 TABLE 98 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 99 ASIA PACIFIC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                 TABLE 100 ASIA PACIFIC: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 101 ASIA PACIFIC: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 102 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 103 ASIA PACIFIC: MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION)
                 TABLE 104 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
                 10.2.1 CHINA
                            10.2.1.1 Declining birth rate to drive demand for IVF procedures
                                         TABLE 105 CHINA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 106 CHINA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 107 CHINA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 10.2.2 JAPAN
                            10.2.2.1 Growing awareness to boost adoption of IVF procedures
                                         TABLE 108 JAPAN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 109 JAPAN: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 110 JAPAN: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.2.3 INDIA
                            10.2.3.1 Rising medical tourism to offer high-growth opportunities for IVF market players
                                         TABLE 111 INDIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 112 INDIA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 113 INDIA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 10.2.4 AUSTRALIA
                            10.2.4.1 Government initiatives to support market growth
                                         TABLE 114 AUSTRALIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 115 AUSTRALIA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 116 AUSTRALIA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 10.2.5 SOUTH KOREA
                            10.2.5.1 Rising R&D activities to positively impact market growth
                                         TABLE 117 SOUTH KOREA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 118 SOUTH KOREA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 119 SOUTH KOREA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.2.6 REST OF ASIA PACIFIC
                            TABLE 120 ROAPAC: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                            TABLE 121 ROAPAC: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 122 ROAPAC: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
         10.3 EUROPE
                 TABLE 123 EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 124 EUROPE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                 TABLE 125 EUROPE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 126 EUROPE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 127 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 128 EUROPE: MARKET, BY CYCLE, 2019–2026 (USD MILLION)
                 TABLE 129 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
                 10.3.1 GERMANY
                            10.3.1.1 Favorable funding scenario for IVF treatments to drive market growth
                                         TABLE 130 GERMANY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 131 GERMANY: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 132 GERMANY: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.3.2 UK
                            10.3.2.1 Supportive regulatory framework to enhance market growth
                                         FIGURE 30 UK: NUMBER OF IVF CYCLES, BY EGG AND SPERM SOURCE, 2010-2019
                                         TABLE 133 UK: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 134 UK: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 135 UK: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.3.3 FRANCE
                            10.3.3.1 Rising healthcare spending to drive market growth
                                         TABLE 136 FRANCE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 137 FRANCE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 138 FRANCE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 10.3.4 ITALY
                            10.3.4.1 Decreasing fertility rates to drive demand for IVF procedures
                                         TABLE 139 ITALY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 140 ITALY: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 141 ITALY: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.3.5 SPAIN
                            10.3.5.1 Increasing fertility tourism to boost market
                                         TABLE 142 SPAIN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 143 SPAIN: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 144 SPAIN: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 10.3.6 REST OF EUROPE
                            TABLE 145 ROE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                            TABLE 146 ROE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 147 ROE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
         10.4 NORTH AMERICA
                 TABLE 148 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 149 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                 TABLE 150 NORTH AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 151 NORTH AMERICA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 152 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 153 NORTH AMERICA: MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION)
                 TABLE 154 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
                 10.4.1 US
                            10.4.1.1 Increasing healthcare expenditure drives IVF market
                                         TABLE 155 US: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 156 US: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 157 US: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.4.2 CANADA
                            10.4.2.1 High cost of in vitro fertilization to restrain market growth
                                         TABLE 158 CANADA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 159 CANADA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 160 CANADA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
         10.5 LATIN AMERICA
                 TABLE 161 LATAM: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                 TABLE 162 LATAM: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                 TABLE 163 LATAM: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 164 LATAM: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 165 LATAM: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 166 LATAM: MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION)
                 TABLE 167 LATAM: MARKET, BY END USER, 2019–2026 (USD MILLION)
                 10.5.1 BRAZIL
                            10.5.1.1 Supportive government regulations drive market
                                         TABLE 168 BRAZIL: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 169 BRAZIL: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 170 BRAZIL: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 171 MEXICO: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                         TABLE 172 MEXICO: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                         TABLE 173 MEXICO: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 10.5.2 REST OF LATIN AMERICA
                            TABLE 174 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                            TABLE 175 REST OF LATIN AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 176 REST OF LATIN AMERICA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
         10.6 MIDDLE EAST & AFRICA
                 10.6.1 RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
                            TABLE 177 MEA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                            TABLE 178 MEA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 179 MEA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 180 MEA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
                            TABLE 181 MEA: MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION)
                            TABLE 182 MEA: MARKET, BY END USER, 2019–2026 (USD MILLION)

    11 COMPETITIVE LANDSCAPE (Page No. - 182)
         11.1 OVERVIEW
         11.2 KEY PLAYER STRATEGIES
         11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
                 FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN IN VITRO FERTILIZATION MARKET
         11.4 MARKET SHARE ANALYSIS (2020)
                 TABLE 183 IN VITRO FERTILIZATION MARKET: DEGREE OF COMPETITION
         11.5 COMPETITIVE LEADERSHIP MAPPING
                 11.5.1 STARS
                 11.5.2 PERVASIVE PLAYERS
                 11.5.3 EMERGING LEADERS
                 11.5.4 PARTICIPANTS
                            FIGURE 32 IN VITRO FERTILIZATION MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
         11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
                 11.6.1 PROGRESSIVE COMPANIES
                 11.6.2 STARTING BLOCKS
                 11.6.3 RESPONSIVE COMPANIES
                 11.6.4 DYNAMIC COMPANIES
                            FIGURE 33 IN VITRO FERTILIZATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020
         11.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN GLOBAL MARKET
                 11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN GLOBAL MARKET
                            TABLE 184 PRODUCT FOOTPRINT OF COMPANIES
                            TABLE 185 REGIONAL FOOTPRINT OF COMPANIES
         11.8 COMPETITIVE SCENARIO
                 11.8.1 IN VITRO FERTILIZATION MARKET: PRODUCT LAUNCHES AND REGULATORY APPROVALS
                            TABLE 186 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY 2018–AUGUST 2021
                 11.8.2 GLOBAL MARKET: DEALS
                            TABLE 187 KEY DEALS, JANUARY 2018–AUGUST 2021
                 11.8.3 GLOBAL MARKET: OTHER DEVELOPMENTS
                            TABLE 188 OTHER KEY DEVELOPMENTS, JANUARY 2018–AUGUST 2021

    12 COMPANY PROFILES (Page No. - 194)
         12.1 MAJOR COMPANIES
    (Business Overview, Products Offered, Recent Developments, MnM View)* 
                 12.1.1 THE COOPER COMPANIES INC.
                            TABLE 189 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW
                            FIGURE 34 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020)
                            TABLE 190 THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS
                 12.1.2 COOK GROUP
                            TABLE 191 COOK GROUP: BUSINESS OVERVIEW
                            TABLE 192 COOK GROUP: PRODUCT OFFERINGS
                 12.1.3 VITROLIFE
                            TABLE 193 VITROLIFE: BUSINESS OVERVIEW
                            FIGURE 35 VITROLIFE: COMPANY SNAPSHOT (2020)
                            TABLE 194 VITROLIFE: PRODUCT OFFERINGS
                 12.1.4 THERMO FISHER SCIENTIFIC
                            TABLE 195 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                            FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
                            TABLE 196 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
                 12.1.5 HAMILTON THORNE LTD.
                            TABLE 197 HAMILTON THORNE LTD.: BUSINESS OVERVIEW
                            FIGURE 37 HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020)
                            TABLE 198 HAMILTON THORNE LTD.: PRODUCT OFFERINGS
                 12.1.6 ESCO MICRO PTE. LTD.
                            TABLE 199 ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW
                            TABLE 200 ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS
                 12.1.7 GENEA LIMITED
                            TABLE 201 GENEA LIMITED: BUSINESS OVERVIEW
                            TABLE 202 GENEA LIMITED: PRODUCT OFFERINGS
                 12.1.8 IVFTECH APS
                            TABLE 203 IVFTECH APS: BUSINESS OVERVIEW
                            TABLE 204 IVFTECH APS: PRODUCT OFFERINGS
                 12.1.9 FUJIFILM IRVINE SCIENTIFIC
                            TABLE 205 FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW
                            FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
                            TABLE 206 FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS
                 12.1.10 THE BAKER COMPANY, INC.
                            TABLE 207 THE BAKER COMPANY, INC.: BUSINESS OVERVIEW
                            TABLE 208 THE BAKER COMPANY, INC.: PRODUCTS OFFERED
                 12.1.11 KITAZATO CORPORATION
                            TABLE 209 KITAZATO CORPORATION: BUSINESS OVERVIEW
                            TABLE 210 KITAZATO CORPORATION: PRODUCTS OFFERED
                 12.1.12 CORNING INCORPORATED
                            TABLE 211 THE CORNING INCORPORATED.: BUSINESS OVERVIEW
                            FIGURE 39 CORNNG INCORPORTAED: COMPANY SNAPSHOT (2020)
                            TABLE 212 CORNING INCORPORATED.: PRODUCT OFFERINGS
                 12.1.13 ZEISS GROUP
                            TABLE 213 ZEISS GROUP: BUSINESS OVERVIEW
                            FIGURE 40 ZEISS GROUP: COMPANY SNAPSHOT (2020)
                            TABLE 214 ZEISS GROUP: PRODUCT OFFERINGS
                 12.1.14 FERTIPRO NV
                            TABLE 215 FERTIPRO NV : BUSINESS OVERVIEW
                            TABLE 216 FERTIPRO NV: PRODUCT OFFERINGS
                 12.1.15 EPPENDORF
                            TABLE 217 EPPENDORF.: BUSINESS OVERVIEW
                            FIGURE 41 EPPENDORF: COMPANY SNAPSHOT (2020)
                            TABLE 218 EPPENDORF.: PRODUCT OFFERINGS
          12.2 OTHER COMPANIES
                 12.2.1 DXNOW, INC.
                 12.2.2 NIDACON INTERNATIONAL AB
                 12.2.3 MICROTECH IVF S.R.O.
                 12.2.4 SAR HEALTHLINE PVT. LTD.
                 12.2.5 INVITROCARE INC.
    *Details on Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies. 
          
    13 APPENDIX (Page No. - 234)
         13.1 DISCUSSION GUIDE
         13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
         13.3 AVAILABLE CUSTOMIZATIONS
         13.4 RELATED REPORTS
         13.5 RELATED REPORTS 
        

    The study involved four major activities to estimate the current size of the in vitro fertilization market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulatory bodies, and publications from government sources such as World Health Organization (WHO), World Bank, Human Fertilization and Embryology Authority (HFEA), International Federation of Fertility Societies (IFFS), American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE), Australia and New Zealand Assisted Reproduction Database (ANZARD), Centers for Disease Control and Prevention (CDC), were referred to identify and collect information for the in vitro fertilization market study.

    Primary Research

    The in vitro fertilization market comprises several stakeholders such as manufacturers Of in vitro fertilization equipment, reagents & media, and accessories market research and consulting firms. The demand side of this market is characterized by the rise in number of fertility clinics, decline in fertility rates,   presence of well established players in the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

    In vitro fertilization /IVF Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the in vitro fertilization market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry and markets have been identified through extensive secondary research
    • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

    In vitro fertilization /IVF Market Size, and Share

    In vitro fertilization /IVF Market Size, and Share

    Data Triangulation

    After arriving at the overall size of the global in vitro fertilization market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Report Objectives

    • To define, describe, and forecast the global in vitro fertilization market on the basis of product, modality, usage, disease indication, and region.
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
    • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
    • To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
    • To profile the key market players and comprehensively analyze their market shares and core competencies2
    • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global in vitro fertilization  market

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global in vitro fertilization market report

    Product Analysis

    • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players.

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5 OEMs)

    Geographic Analysis

    • Further breakdown of the Rest of Europe in vitro fertilization  market into Belgium, Austria,
    • Denmark, Greece, Poland, and Russia, among other countries
    •  Further breakdown of the Rest of Asia Pacific in vitro fertilization  market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
    •  Further breakdown of the Rest of Latin America in vitro fertilization market into Argentina, and Colombia, among other countries.
    In Vitro Fertilization /IVF Market Size,  Share & Growth Report
    Report Code
    MD 4467
    Published ON
    Nov, 2021
    Choose License Type
    BUY NOW
    GET A FREE SAMPLE

    This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

    SEND ME A FREE SAMPLE
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    ©2022 MarketsandMarkets Research Private Ltd. All rights reserved